(Q37987428)

26 August 2017

title

Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases (English)

1 reference

stem cell transplantation

26 August 2017

main subject

1 reference

Alan Tyndall

1

1 reference

26 August 2017

language of work or name

English

0 references

publication date

22 February 2012

1 reference

26 August 2017

1 reference

26 August 2017

volume

71

1 reference

26 August 2017

issue

4 Pt 2

1 reference

26 August 2017

page(s)

433-438

1 reference

https://scigraph.springernature.com/pub.10.1038/pr.2011.66

26 August 2017

exact match

0 references

cites work

Autologous haemopoietic stem cell transplantation in a patient with severe pulmonary hypertension complicating connective tissue disease

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Blood and marrow stem cell transplants in auto-immune disease: a consensus report written on behalf of the European League against Rheumatism (EULAR) and the European Group for Blood and Marrow Transplantation (EBMT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Regulatory T cells in autologous stem cell transplantation for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Capillary regeneration in scleroderma: stem cell therapy reverses phenotype?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous Stem cell Transplantation International Scleroderma (ASTIS) trial: hope on the horizon for patients with severe systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: Two faces of the same coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Minimal T-cell requirements for triggering haemophagocytosis associated with Epstein-Barr virus-driven B-cell proliferation: a clinical case study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Acquired hemophilia-A in a patient with multiple sclerosis treated with autologous hematopoietic stem cell transplantation and interferon beta-1a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Successful autologous stem cell transplantation in two patients with juvenile dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Multipotent mesenchymal stromal cells for autoimmune diseases: teaching new dogs old tricks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

EMT: when epithelial cells decide to become mesenchymal-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Fibroblast growth factor 2 and platelet-derived growth factor, but not platelet lysate, induce proliferation-dependent, functional class II major histocompatibility complex antigen in human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

The survey on cellular and engineered tissue therapies in Europe in 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous progenitor cell implantation as a novel therapeutic intervention for ischaemic digits in systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Mesenchymal stem cell transplantation for diffuse alveolar hemorrhage in SLE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous mesenchymal stem cells foster revascularization of ischemic limbs in systemic sclerosis: a case report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Skin involvement in scleroderma--where histological and clinical scores meet

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous hematopoietic stem cell transplantation for autoimmune diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Nail fold capillaroscopy differs widely between systemic sclerosis and chronic graft vs host disease of the skin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Immunology. Replacing an immune system gone haywire

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Stem cells: HSCT for systemic sclerosis--swallows and summers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Current perspectives of autologous stem cell transplantation for severe Juvenile Idiopathic Arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

31 March 2020

All MSCs are pericytes?

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Why do we need noncommercial, investigator-initiated clinical trials?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Rapid improvement of nailfold capillaroscopy after intense immunosuppression for systemic sclerosis and mixed connective tissue disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Allogeneic mesenchymal stem cells transplantation in treatment of multiple sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

Autologous mesenchymal stem cell treatment increased T regulatory cells with no effect on disease activity in two systemic lupus erythematosus patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FPR.2011.66

31 March 2020

Identifiers

DOI

10.1038/PR.2011.66

1 reference

Dimensions Publication ID

26 August 2017

1042175079

0 references

1 reference